Wilson Thomas A, Nicolosi Robert J, Delaney Bryan, Chadwell Kim, Moolchandani Vikas, Kotyla Timothy, Ponduru Sridevi, Zheng Guo-Hua, Hess Richard, Knutson Nathan, Curry Leslie, Kolberg Lore, Goulson Melanie, Ostergren Karen
Center for Health and Disease Research, Department of Health and Clinical Sciences, University of Massachusetts-Lowell, Lowell, MA 01854, USA.
J Nutr. 2004 Oct;134(10):2617-22. doi: 10.1093/jn/134.10.2617.
Consumption of concentrated barley beta-glucan lowers plasma cholesterol because of its soluble dietary fiber nature. The role of molecular weight (MW) in lowering serum cholesterol is not well established. Prior studies showed that enzymatic degradation of beta-glucan eliminates the cholesterol-lowering activity; however, these studies did not evaluate the MW of the beta-glucan. The current study was conducted to evaluate whether barley beta-glucan concentrates, partially hydrolyzed to reduce MW, possess cholesterol-lowering and antiatherogenic activities. The reduced MW fraction was compared with a high MW beta-glucan concentrate from the same barley flour. Concentrated beta-glucan preparations were evaluated in Syrian Golden F(1)B hamsters fed a hypercholesterolemic diet (HCD) with cholesterol, hydrogenated coconut oil, and cellulose. After 2 wk, hamsters were fed HCD or diets that contained high or reduced MW beta-glucan at a concentration of 8 g/100 g at the expense of cellulose. Decreases in plasma total cholesterol (TC) and non-HDL-cholesterol (non-HDL-C) concentrations occurred in the hamsters fed reduced MW and high MW beta-glucan diets. Plasma HDL-C concentrations did not differ. HCD-fed hamsters had higher plasma triglyceride concentrations. Liver TC, free cholesterol, and cholesterol ester concentrations did not differ. Aortic cholesterol ester concentrations were lower in the reduced MW beta-glucan-fed hamsters. Consumption of either high or reduced MW beta-glucan increased concentrations of fecal total neutral sterols and coprostanol, a cholesterol derivative. Fecal excretion of cholesterol was greater than in HCD-fed hamsters only in those fed the reduced MW beta-glucan. Study results demonstrate that the cholesterol-lowering activity of barley beta-glucan may occur at both lower and higher MW.
由于其可溶性膳食纤维的特性,食用浓缩大麦β-葡聚糖可降低血浆胆固醇。分子量(MW)在降低血清胆固醇中的作用尚未完全明确。先前的研究表明,β-葡聚糖的酶促降解会消除其降胆固醇活性;然而,这些研究并未评估β-葡聚糖的分子量。本研究旨在评估部分水解以降低分子量的大麦β-葡聚糖浓缩物是否具有降胆固醇和抗动脉粥样硬化活性。将降低分子量的部分与来自同一大麦粉的高分子量β-葡聚糖浓缩物进行比较。在喂食含胆固醇、氢化椰子油和纤维素的高胆固醇饮食(HCD)的叙利亚金黄F(1)B仓鼠中评估浓缩β-葡聚糖制剂。2周后,仓鼠改喂HCD或含有浓度为8 g/100 g的高分子量或降低分子量β-葡聚糖的饮食,以纤维素替代。喂食降低分子量和高分子量β-葡聚糖饮食的仓鼠血浆总胆固醇(TC)和非高密度脂蛋白胆固醇(non-HDL-C)浓度降低。血浆高密度脂蛋白胆固醇(HDL-C)浓度无差异。喂食HCD的仓鼠血浆甘油三酯浓度较高。肝脏TC、游离胆固醇和胆固醇酯浓度无差异。喂食降低分子量β-葡聚糖的仓鼠主动脉胆固醇酯浓度较低。食用高分子量或降低分子量的β-葡聚糖均会增加粪便总中性固醇和粪甾烷醇(一种胆固醇衍生物)的浓度。仅在喂食降低分子量β-葡聚糖的仓鼠中,胆固醇的粪便排泄量大于喂食HCD的仓鼠。研究结果表明,大麦β-葡聚糖的降胆固醇活性可能在较低和较高分子量时均会出现。